Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 282751-282800 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT00068380
A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer
PHASE2
Completed
17 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2010
2 conditions
1 sponsor
1 location
NCT01163110
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy
PHASE1
Completed
32 participants
Started: Mar 31, 2004 · Completed: Jun 30, 2007
3 conditions
1 sponsor
1 location
NCT01780493
The Long Term Follow-Up Results Of The Direct Nipple Ureteroneocystostomy Technique
NA
Completed
19 participants
Started: Mar 31, 2004 · Completed: Aug 31, 2011
2 conditions
1 sponsor
1 location
NCT01354834
Assessment of the Effectiveness of Menopur in Intrauterine Insemination
N/A
Completed
207 participants
Started: Mar 31, 2004 · Completed: Apr 30, 2006
1 condition
2 sponsors
14 locations
NCT00652262
BAY38-9456 - Supportive Trial for Spinal Injury
PHASE3
Completed
32 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2004
3 conditions
1 sponsor
3 locations
NCT00075569
SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
PHASE2
Completed
64 participants
Started: Mar 31, 2004 · Completed: Aug 31, 2005
2 conditions
2 sponsors
2 locations
NCT00684762
Fasted Bioavailability Study of Cilostazol Tablets, 100 mg
PHASE1
Completed
32 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2004
1 condition
1 sponsor
0 locations
NCT00486161
Acylated Ghrelin Response to Acute Exercise in Obesity
N/A
Completed
16 participants
Started: Mar 31, 2004 · Completed: Dec 31, 2006
1 condition
1 sponsor
1 location
NCT00696085
Fetal Alcohol Damage Prevention Study
NA
Completed
612 participants
Started: Mar 31, 2004 · Completed: Feb 29, 2008
2 conditions
1 sponsor
1 location
NCT00451997
Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
PHASE2
Completed
10 participants
Started: Mar 31, 2004 · Completed: Apr 30, 2007
2 conditions
2 sponsors
1 location
NCT00524238
Metabolic Changes in Hypothyroid Patients
NA
Completed
22 participants
Started: Mar 31, 2004 · Completed: Aug 31, 2006
1 condition
1 sponsor
1 location
NCT00088205
Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma
PHASE2
Completed
60 participants
Started: Mar 31, 2004 · Completed: May 31, 2008
1 condition
1 sponsor
17 locations
NCT00588003
Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer
PHASE1
Completed
45 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2009
1 condition
1 sponsor
1 location
NCT00126204
Adjunctive Treatment With Doxycycline to Enhance the Durability of Endovascular Aortic Aneurysm Repair
NA
Completed
75 participants
Started: Mar 31, 2004 · Completed: Jul 31, 2006
1 condition
1 sponsor
1 location
NCT02231372
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
N/A
Completed
4,602 participants
Started: Mar 31, 2004
1 condition
1 sponsor
0 locations
NCT00101569
Aripiprazole Oral Acceptability Trial
PHASE3
Completed
59 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2005
1 condition
2 sponsors
7 locations
NCT00183573
HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic
PHASE2/PHASE3
Completed
1,554 participants
Started: Mar 31, 2004 · Completed: Jul 31, 2007
2 conditions
4 sponsors
1 location
NCT00661908
Diabetes-Related Discrimination at Workplace and by Insurances
N/A
Completed
509 participants
Started: Mar 31, 2004 · Completed: Jan 31, 2008
1 condition
2 sponsors
0 locations
NCT01965080
Exemestane in Advanced and Recurrent Endometrial Carcinoma
PHASE2
Completed
52 participants
Started: Mar 31, 2004 · Completed: Feb 28, 2009
1 condition
1 sponsor
1 location
NCT00185484
Efficacy and Safety Oral Contraceptive Study
PHASE3
Completed
1,113 participants
Started: Mar 31, 2004 · Completed: Jan 31, 2006
1 condition
1 sponsor
0 locations
NCT00225199
Efficacy and Safety of SH T00660AA in Treatment of Endometriosis
PHASE3
Completed
198 participants
Started: Mar 31, 2004 · Completed: Sep 30, 2006
1 condition
1 sponsor
0 locations
NCT00620516
Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients
N/A
Completed
3,008 participants
Started: Mar 31, 2004
1 condition
1 sponsor
71 locations
NCT00081770
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)
PHASE3
Completed
4,469 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2007
1 condition
1 sponsor
0 locations
NCT00925730
Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion
PHASE4
Completed
20 participants
Started: Mar 31, 2004
1 condition
1 sponsor
2 locations
NCT00946751
To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions
PHASE1
Completed
20 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2004
1 condition
1 sponsor
0 locations
NCT01980550
Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy
PHASE4
Completed
250 participants
Started: Mar 31, 2004 · Completed: Dec 31, 2004
1 condition
2 sponsors
0 locations
NCT00078611
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
PHASE3
Completed
462 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2005
1 condition
2 sponsors
75 locations
NCT00105794
Psychiatric Advance Directives for Improved Mental Health Care
NA
Completed
360 participants
Started: Mar 31, 2004 · Completed: Jun 30, 2007
5 conditions
1 sponsor
1 location
NCT00257348
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
PHASE2
Completed
5 participants
Started: Mar 31, 2004 · Completed: Jul 31, 2007
1 condition
2 sponsors
1 location
NCT02171663
Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors
PHASE1
Completed
43 participants
Started: Mar 31, 2004
1 condition
1 sponsor
0 locations
NCT01285258
Emergency Peripartum Hysterectomy: A Prospective Study in Iran
PHASE2
Completed
41 participants
Started: Mar 31, 2004 · Completed: Mar 31, 2009
1 condition
1 sponsor
1 location
NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer
PHASE2
Completed
33 participants
Started: Mar 31, 2004 · Completed: Sep 30, 2008
5 conditions
1 sponsor
1 location
NCT00075894
Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
PHASE1
Completed
18 participants
Started: Mar 31, 2004
1 condition
1 sponsor
5 locations
NCT00360386
"ALBION Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"
PHASE2
Completed
110 participants
Started: Mar 31, 2004 · Completed: Feb 28, 2005
1 condition
2 sponsors
0 locations
NCT00178126
An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions
NA
Completed
232 participants
Started: Mar 31, 2004 · Completed: Oct 31, 2008
1 condition
2 sponsors
1 location
NCT00191035
Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD
PHASE4
Completed
520 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2006
1 condition
1 sponsor
21 locations
NCT00118443
Evaluation of a School-Based Training Program for Suicide Prevention
PHASE2/PHASE3
Completed
50,000 participants
Started: Mar 31, 2004 · Completed: Dec 31, 2006
1 condition
2 sponsors
1 location
NCT00078572
Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
PHASE3
Completed
408 participants
Started: Mar 31, 2004 · Completed: Feb 28, 2010
1 condition
1 sponsor
0 locations
NCT00565981
A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response
PHASE2
Completed
10 participants
Started: Mar 31, 2004 · Completed: Feb 13, 2008
1 condition
2 sponsors
8 locations
NCT00147277
ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
PHASE4
Completed
925 participants
Started: Mar 31, 2004 · Completed: Jan 31, 2008
2 conditions
1 sponsor
1 location
NCT00118820
Antibiotic Efficacy in Third Molar Surgery
PHASE3
Completed
132 participants
Started: Mar 31, 2004 · Completed: Jun 30, 2006
3 conditions
2 sponsors
1 location
NCT00091650
Olanzapine in Patients With Borderline Personality Disorder
PHASE3
Completed
300 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2005
1 condition
1 sponsor
39 locations
NCT00185549
An Interactive Program to Improve Care for Children With CF
NA
Completed
60 participants
Started: Mar 31, 2004 · Completed: Sep 30, 2005
1 condition
1 sponsor
1 location
NCT00798889
Rollover Protocol for Prior SU011248 Protocols
NA
Completed
314 participants
Started: Mar 31, 2004 · Completed: Dec 31, 2011
1 condition
1 sponsor
59 locations
NCT00081601
Study of CEP-701 in Treatment of Prostate Cancer
PHASE2
Completed
30 participants
Started: Mar 31, 2004 · Completed: Jun 30, 2005
1 condition
1 sponsor
1 location
NCT00254657
Levetiracetam for Treatment of Pain Associated With Fibromyalgia
NA
Completed
66 participants
Started: Mar 31, 2004 · Completed: Apr 30, 2005
1 condition
2 sponsors
1 location
NCT00186069
Magnesium Sulfate vs Placebo for Placental Abruption
NA
Completed
30 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2017
1 condition
2 sponsors
2 locations
NCT00638859
Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia
PHASE3
Completed
56 participants
Started: Mar 31, 2004 · Completed: Oct 31, 2004
1 condition
1 sponsor
1 location
NCT00313703
Prospective ED Headache Cohort Study
N/A
Completed
477 participants
Started: Mar 31, 2004 · Completed: Nov 30, 2005
1 condition
2 sponsors
1 location
NCT00095381
Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
PHASE2
Completed
20 participants
Started: Mar 31, 2004 · Completed: Dec 31, 2007
1 condition
1 sponsor
24 locations
Previous
1
More pages
5653
5654
5655
5656
5657
5658
5659
More pages
6093
Next